These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12710291)

  • 61. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Medical treatment in peripheral arterial disease: a professional practice study in 262 patients].
    Dumas C; Sedighian S; Nangou P; Boukriche Y; Simorre B; Oziol E; Reny JL
    Rev Med Interne; 2007 Feb; 28(2):71-8. PubMed ID: 17157964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 65. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
    Berger AK; Duval S; Krumholz HM
    J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Secondary prevention for coronary artery disease: are we following the guidelines?
    Syed IA; Riaz A; Ryan A; Reilly MO
    Ir J Med Sci; 2010 Dec; 179(4):535-7. PubMed ID: 20676796
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Outpatient management of heart failure in the United States, 2006-2008.
    Mosalpuria K; Agarwal SK; Yaemsiri S; Pierre-Louis B; Saba S; Alvarez R; Russell SD
    Tex Heart Inst J; 2014 Jun; 41(3):253-61. PubMed ID: 24955039
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of evidence-based interventions in acute coronary syndrome - Subanalysis of the ACCEPT registry.
    Wang R; Neuenschwander FC; Lima Filho A; Moreira CM; Santos ES; Reis HJ; Romano ER; Mattos LA; Berwanger O; Andrade JP
    Arq Bras Cardiol; 2014 Apr; 102(4):319-26. PubMed ID: 24652052
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
    Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
    Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Meisinger C
    Eur J Intern Med; 2018 Jan; 47():62-68. PubMed ID: 28826823
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.
    Alberts MJ; Bhatt DL; Mas JL; Ohman EM; Hirsch AT; Röther J; Salette G; Goto S; Smith SC; Liau CS; Wilson PW; Steg PG;
    Eur Heart J; 2009 Oct; 30(19):2318-26. PubMed ID: 19720633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Underuse of cardioprotective medications in patients prior to acute myocardial infarction.
    Miller RR; Li YF; Sun H; Kopjar B; Sales AE; Piñeros SL; Fihn SD
    Am J Cardiol; 2003 Jul; 92(2):209-11. PubMed ID: 12860227
    [No Abstract]   [Full Text] [Related]  

  • 78. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.
    Komajda M; Follath F; Swedberg K; Cleland J; Aguilar JC; Cohen-Solal A; Dietz R; Gavazzi A; Van Gilst WH; Hobbs R; Korewicki J; Madeira HC; Moiseyev VS; Preda I; Widimsky J; Freemantle N; Eastaugh J; Mason J;
    Eur Heart J; 2003 Mar; 24(5):464-74. PubMed ID: 12633547
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interhospital Variability in Drug Prescription After Acute Coronary Syndrome: Insights From the ACDC Study.
    Ferreira-González I; Carrillo X; Martín V; de la Torre Hernández JM; Baz JA; Navarro Manchón J; Masotti M; Cequier Á; Cárdenas M; Alfonso Manterola F;
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):117-24. PubMed ID: 26253861
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.